Impact of subclinical hypothyroidism treatment in systolic and diastolic cardiac function

Arq Bras Endocrinol Metabol. 2011 Oct;55(7):460-7. doi: 10.1590/s0004-27302011000700005.

Abstract

Objective: To evaluate the effects of levothyroxine (L-T4) replacement in echocardiographic parameters of middle-aged women with subclinical hypothyroidism (SH).

Subjects and methods: This was a randomized, double-blind, placebo-controlled study. Echocardiographic evaluation was carried out at baseline and one year after restoration of euthyroidism. Thirty-three women with SH were assigned to one of two groups (L-T4 or placebo).

Results: The two groups had similar basal characteristics. There was a significant deterioration of left ventricular Tei index after one year of placebo use, which differed from the effect of L-T4 replacement (+0.086 ± 0.092 vs. -0.014 ± 0.012; p = 0.047). There was also a slight reduction in cardiac output and cardiac index with placebo use, which was not different from L-T4 effect.

Conclusion: Results suggest a positive impact of L-T4 replacement in cardiac function of middle-aged women with SH.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Cardiac Output / drug effects
  • Cardiac Output / physiology
  • Diastole / drug effects
  • Double-Blind Method
  • Female
  • Heart / drug effects*
  • Heart / physiopathology
  • Hormone Replacement Therapy / adverse effects*
  • Humans
  • Hypothyroidism / diagnostic imaging
  • Hypothyroidism / drug therapy
  • Hypothyroidism / physiopathology*
  • Middle Aged
  • Statistics, Nonparametric
  • Systole / drug effects
  • Thyroxine / adverse effects*
  • Thyroxine / therapeutic use
  • Treatment Outcome
  • Ultrasonography
  • Ventricular Function, Left / drug effects

Substances

  • Thyroxine